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believe that priority assessment in patients awaiting heart transplanta-
tion on the basis of QT dispersion measurements is premature.
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Reply
We appreciate the interest of Zabel and colleagues in our recent
report (1). We also agree that it is important to be clear regarding the
interpretation of our results. We would like to respond to their
comments.
1. The analysis of QT dispersion risk used two different measures of
dispersion: the maximal 2 minimal QT interval (QTDISP) and the
coefficient of variation of all QT intervals (QTCV). These variables
were highly significant (p 5 0.009 and p 5 0.001, respectively) when
analyzed as continuous variables without selection of a cutoff. The
dichotomization of patients on the basis of a cutoff for QTDISP of
140 ms and QTCV of 9% presented in our report was for illustrative
purposes only. The actual statistical model yields a continuum of risk
based on the value for QTDISP and QTCV. The significance of these
predictors remained after adjustment for other potential risk factors in
a multivariate analysis and after the removal of the 13 subjects with
atrial fibrillation. It can be seen in the original report that all analyses
consistently showed the utility of QT dispersion as a risk factor when
measured as described in the patient cohort under study (1).
Recent prospective studies (1,2) have demonstrated a significant
correlation between QT dispersion and mortality in patients with heart
failure, although some preliminary studies may suggest otherwise. It is
reasonable to assume that patients awaiting heart transplantation
represent a sicker subset of patients whose data may not be extrapo-
lated to patients with heart failure in general. We look forward to
reading the final published reports on the subject alluded to by Zabel
and colleagues (3,4).
2. The issue is raised that U waves may have contributed to an
increase in measured QT dispersion in the patients studied.
However, U waves were not included in the analysis (1) and therefore
did not contribute to increased QT dispersion in the original report.
3. In terms of electrocardiographic (ECG) analysis, the ECGs were
read by two independent observers blinded as to outcome, with the aid
of a magnifying lens, without a digitizing pad. The method for
obtaining ECGs was, as surmized, a standard 4 3 3 format. We used
this ECG format because it is currently the standard method for
obtaining ECGs and therefore most widely applicable with existing
equipment. Although transient changes in heart rate during the brief
period of acquisition could have affected QT dispersion, we doubt that
a sizable and systematic pattern would have occurred that would have
affected its measurement.
4. We considered the possibility that patients with atrial fibrillation
whose RR intervals can vary from beat to beat could have affected the
interpretation of our data. In fact, not only did we consider this
possibility, but we included specific data on this subject in the
published report (1). Although patients with atrial fibrillation were
included in most of the overall analyses, we did report specific data in
which the 13 patients with atrial fibrillation were excluded from
analysis (see Fig. 3 and the results and discussion sections). Indexes of
QT dispersion remained significant predictors of risk both before and
after the 13 subjects with atrial fibrillation were removed from the
analysis.
As ardent students of the scientific process, we hope that our work
serves as the springboard for additional studies in this area, so that we
can ultimately know how to best select patients who are still likely to
die while awaiting a donor heart.
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Echocardiography in Staphylococcus
aureus Bacteremia
Fowler et al. (1) investigated the diagnostic and prognostic usefulness
of transesophageal echocardiography (TEE) in patients with Staphy-
lococcus aureus bacteremia. The authors suggest that infective endo-
carditis is common in patients with S. aureus bacteremia and is
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